Jupiter Life Line hospitals secures ₹500 crore term loan from HDFC Bank

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Jupiter Life Line Hospitals signed a ₹500 crore term loan agreement with HDFC Bank on October 18, 2026.
  • The facility includes a ₹300 crore sublimit specifically for Letter of Credit (LC) purposes.
  • Security comprises exclusive charges on Dombivli and Pune Baner hospital properties via mortgage.
  • Pari passu charge is created on current assets and receivables; no related party implications noted.
powered bylight_fuzz_icon
53936589

*this image is generated using AI for illustrative purposes only.

Jupiter Life Line Hospitals Limited has executed a ₹500 crore term loan facility with HDFC Bank to fund its capital expenditure requirements. The agreement, signed on October 18, 2026, includes a sublimit of ₹300 crore designated for Letter of Credit (LC) facilities.

The financing arrangement involves exclusive charges on the company’s Dombivli and Pune Baner hospital properties. These immovable assets are mortgaged to secure the debt. Additionally, tangible movable assets are hypothecated, and the lender holds a pari passu charge on current assets and receivables.

Security structure and collateral details

The disclosure highlights specific security provisions granted to the lender. The table below outlines the key terms of the agreement as filed with the stock exchanges.

Particulars Details
Lender HDFC Bank Limited
Borrower Jupiter Life Line Hospitals
Loan Amount ₹500 crore (Term Loan)
Sublimit ₹300 crore (LC Facility)
Purpose Capital Expenditure
Date of Execution October 18, 2026
Outstanding Amount Nil

Collateral specifics

The security package is structured around the company's physical infrastructure. Key elements include:

  • Exclusive Charge: On Dombivli Hospital and Pune Baner Hospital properties.
  • Mortgage: On immovable properties.
  • Hypothecation: On tangible movable assets.
  • Pari Passu Charge: On current assets and receivables.

The filing confirms that the transaction does not fall under related party transactions, as HDFC Bank is not related to the promoter group or group companies. There are no special rights such as director appointments or restrictions on capital structure changes attached to this agreement.

What the numbers show

The inclusion of a ₹300 crore sublimit for LC facilities within the ₹500 crore term loan suggests the company anticipates significant working capital needs alongside long-term asset creation. Typically, term loans are reserved for fixed asset financing, while LCs support trade cycles. This hybrid structure indicates Jupiter Life Line is optimizing its balance sheet to cover both expansion costs and operational liquidity requirements simultaneously.

Historical Stock Returns for Jupiter Life Line Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-0.69%-4.05%-11.38%-3.70%-19.84%+14.04%

How will the ₹500 crore capital expenditure impact Jupiter Life Line's bed capacity expansion and revenue growth trajectory over the next 24 months?

What is the projected increase in interest expense for Jupiter Life Line, and how might this affect its EBITDA margins in the upcoming fiscal quarters?

Given the exclusive mortgage on Dombivli and Pune Baner properties, how does this collateral structure limit the company's future debt-raising capacity for additional hospital projects?

Jupiter Life Line Hospital
View Company Insights
View All News
like17
dislike

Jupiter Life Line Hospitals to host Q2FY27 earnings call on Oct 26

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Earnings call scheduled for October 26, 2026 at 10:00 am IST
  • Management to discuss Q2 and H1 FY27 operational and financial performance
  • Pre-registration required for investor participation
powered bylight_fuzz_icon
53013685

*this image is generated using AI for illustrative purposes only.

Jupiter Life Line Hospitals Limited will host its earnings conference call for Q2 and H1 FY27 on Monday, October 26, 2026, at 10:00 am IST. The session will cover the company's operational and financial performance for the period.

The management team, led by Managing Director and CEO Ankit Thakker, will address queries from investors and analysts. The official invite for the call is available on the company's website.

Call details and access

Participants are requested to pre-register for the event via the provided link. The following access numbers are available for joining the conference:

Region Access Number
India (Primary) +91 22 6280 1309
India (Primary) +91 22 7115 8210
USA 18667462133
UK 08081011573
Singapore 8001012045
Hong Kong 800964448

Regulatory filing

The intimation was filed with the National Stock Exchange of India and BSE Limited pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was signed by Suma Upparatti, Company Secretary and Compliance Officer, on October 8, 2026.

Historical Stock Returns for Jupiter Life Line Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-0.69%-4.05%-11.38%-3.70%-19.84%+14.04%

How will Jupiter Life Line's Q2 FY27 revenue growth compare to the broader Indian healthcare sector trends?

What specific capital expenditure plans are expected to be announced regarding new hospital expansions or technology upgrades?

How might the upcoming earnings report influence analyst price targets and institutional investor sentiment for the stock?

Jupiter Life Line Hospital
View Company Insights
View All News
like17
dislike

More News on Jupiter Life Line Hospital

1 Year Returns:-19.84%